
Release date: 2026-03-11 16:56:51 Article From: Lucius Laos Recommended: 3
Common reactions include: abnormal liver function (elevated ALT/AST), anemia, decreased platelets, febrile neutropenia, diarrhea, nausea, fatigue, etc. If you experience any of these discomforts, you should contact your doctor promptly to assess whether dose adjustment is needed.
Differentiation Syndrome: Symptoms include fever, difficulty breathing, sudden weight gain, and edema. This condition can be life-threatening in severe cases and requires immediate hospitalization.
Posterior Reversible Encephalopathy Syndrome (PRES): A rare neurological issue that may cause symptoms such as seizures, headache, confusion, and visual disturbances. If these occur, stop the medication immediately and seek medical attention promptly.
QT Interval Prolongation: This can be detected through regular ECG monitoring and requires a doctor's assessment to determine if dose adjustment is necessary.
Pancreatitis: Although a direct link to the drug is not definitively established, if you experience severe upper abdominal pain, nausea, or vomiting, you should seek immediate medical attention and follow the doctor's advice to stop the medication.
Discontinue the medication in the following situations:
If differentiation syndrome does not improve after 48 hours of steroid treatment.
If symptoms suggestive of Posterior Reversible Encephalopathy Syndrome (PRES) appear.
If other severe adverse reactions occur and, after evaluation, the doctor determines that discontinuation is necessary.
Seek immediate medical attention in the following situations:
If symptoms of a serious adverse reaction worsen.
If an acute allergic reaction occurs: such as large hives on the skin, difficulty breathing, or swelling of the face or throat. These can be life-threatening and require emergency care.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1612025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4002024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1552025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1732025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1542025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1882025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1692025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1652025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: